Our results showed that important genes that regulate the cell cycle, such as MYC and the cyclins CCNA2, CCNE2, CCND2, and CDK1, were altered and that their expression was increased in HSCs from patients with AML. This evidence concerns the gene CDK1 and acute myeloid leukemia.